Abstract
The aim of the present study is to investigate the effects of ovarian sex steroid hormones on the expression and the release of several locally active substances by human endometrium. Specific objectives are (1) to ascertain if estradiol 17-β (E2) and progesterone modulate inducible nitric oxide synthase (iNOS) expression and nitric oxide release; (2) to determine whether human endometrium can express High Mobility Group Box 1 (HMGB1), a multifunctional cytokine, and whether sexual steroid hormones can modulate this expression; and (3) to evaluate whether nitric oxide can influence HMGB1 expression in this tissue. Endometrial tissue was obtained from 40 healthy premenopausal women who underwent hysteroscopy for suspected benign gynecological conditions. Endometrium was incubated with E2, progesterone, or sodium nitroprusside, a nitric oxide donor. Nitrite assay was used to quantify stable nitric oxide metabolites in culture medium, and Western blot analysis was used to detect iNOS and HMGB1. Incubation of endometrium with E2 results in an increase in iNOS expression and nitric oxide metabolite production. The opposite effect is obtained by incubating tissues with progesterone. HMGB1 is expressed by human endometrium, and its expression is increased by E2 and decreased by progesterone. Incubation with sodium nitroprusside results in a reduction in HMGB1 expression. Both E2 and progesterone modulate iNOS expression and nitric oxide production in human endometrium. HMGB1 is expressed in the human endometrium, and its expression is modulated by E2, progesterone, and nitric oxide.
Similar content being viewed by others
References
Chwalisz K, Garfield RE. Role of nitric oxide in implantation and menstruation. Hum Reprod. 2000;15(suppl 3):96–111.
Jabbour HN, Kelly RW, Fraser HM, Critchley HOD. Endocrine regulation of menstruation. Endocr Rev. 2006;27:17–46.
Kodaman PH, Taylor HS. Hormonal regulation of implantation. Obstet Gynecol Clin North Am. 2004;31:745–766.
Bian K, Ke Y, Kamisaki Y, Murad F. Proteomic modification by nitric oxide. J Pharmacol Sci. 2006;101:271–279.
Murad F. Nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med. 2006;355:2003–2011.
Norman J, Cameron I. Nitric oxide in the human uterus. Rev Reprod. 2006;1:61–68.
Khorram O, Garthwaite M, Magness RR. Endometrial and myometrial expression of nitric oxide synthase isoforms in pre- and postmenopausal women. J Clin Endocrinol Metab. 1999;84:2226–2232.
Telfer JF, Lyall F, Norman JE, Cameron IT. Identification of nitric oxide synthase in human uterus. Hum Reprod. 1995;10:19–23.
Telfer JF, Irvine GA, Kohnen G, Campbell S, Cameron IT. Expression of endothelial and inducible nitric oxide synthase in non-pregnant and decidualized human endometrium. Mol Hum Reprod. 1997;3:69–75.
Tschugguel W, Schneeberger C, Unfried G, et al. Induction of inducible nitric oxide synthase expression in human secretory endometrium. Hum Reprod. 1998;13:436–444.
Tseng L, Zhang J, Peresleni TY, Goligorsky MS. Cyclic expression of endothelial nitric oxide synthase mRNA in the epithelial glands of human endometrium.J Soc Gynecol Invest. 1996;3:33–38.
Han G, Magee T, Khorram O. Regulation of nitric oxide synthase isoforms by estrogen in the human endometrium. Fertil Steril. 2005;84:1220–1227.
Khorram O. The role of nitric oxide in implantation. Infertil Reprod Med Clin North Am. 2001;12:339–348.
Zervou S, Klentzeris LD, Old RW. Nitric oxide synthase expression and steroid regulation in the uterus of women with menorrhagia. Mol Hum Reprod. 1999;5:1048–1054.
You HJ, Kim JY, Jeong HG. 17 beta-estradiol increases inducible nitric oxide synthase expression in macrophages. Biochem Biophys Res Commun. 2003;303:1129–1134.
Collins P. Vascular effects of oestrogen. Maturitas. 2006;23:217–226.
Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev. 2002;23:665–686.
Fiuza C, Bustin M, Talwar S, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003;101:2652–2660.
Yang H, Wang H, Czura CJ, Tracey KJ. The cytokine activity of HMGB1. J Leukoc Biol. 2005;78:1–8.
Erlandsson Harris H, Andersson U. The nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol. 2004;34:1503–1512.
Jang W, Li J, Gallowitsh-Puerta M, Tracey KJ, Pisetsky DS. The effect of CpG DNA on HMGB1 release by murine macrophages cell lines. J Leukoc Biol. 2005;78:930–936.
Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med. 2004;255:320–331.
Ticconi C, Zicari A, Belmonte A, Realalcci M, Rao ChV, Piccione E. Pregnancy-promoting actions of HCG in human myometrium and fetal membranes. Placenta. 2007;28(suppl A):S137–S143.
Reeves R, Beckerbauer L. HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta. 2001;1519:13–19.
Jiang W, Pisetsky DS. The role of IFN-α and nitric oxide in the release of HMGB1 by RAW 264.7 cells stimulated with polyinosinic-polycytidylic acid or lipopolysaccharide. J Immunol. 2006;177:3337–3343.
Dudley DJ, Hatasaka HH, Ware Branch D, Hammond E, Mitchell MD. A human endometrial explant system: validation and potential applications. Am J Obstet Gynecol. 1992;167:1774–1780.
Ticconi C, Zicari A, Losardo A, Pontieri G, Pasetto N, Piccione E. Nitric oxide in human fetal membranes at term gestation: effect on prostaglandin E2 release. Eur J Obstet Gynecol Reprod Biol. 1996;69:135–139.
Ticconi C, Zicari A, Realacci M, et al. Oxytocin modulates nitric oxide generation by human fetal membranes at term pregnancy. Am J Reprod Immunol. 2004;52:185–191.
Zicari A, Ticconi C, Ietta F, et al. Macrophage migration inhibitory factor-nitric oxide interaction in human fetal membranes at term pregnancy. J Soc Gynecol Invest. 2006;13:263–270.
Tschugguel W, Schneeberger C, Unfried G, et al. Elevation of inducible nitric oxide synthase activity in human endometrium during menstruation. Biol Reprod. 1999;60:297–304.
Sennequier N, Wolan D, Stuehr DJ. Antifungal imidazoles block assembly of inducible NO synthase into an active dimer. J Biol Chem. 1999;274:930–938.
Taylor AH, Guzail M, Wahab M, Thompson JR, Al-Azzawi F. Quantitative histomorphometric analysis of gonadal steroid receptor distribution in the normal human endometrium through the menstrual cycle. Histochem Cell Biol. 2005;123: 463–474.
Bianchi ME. Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death. Trends Cell Biol. 2004;14:287–293.
Rouhiainen A, Kuja-Panula J, Wilkman E, et al. Regulation of monocyte migration by amphoterin (HMGB1). Blood. 2004;104:1174–1182.
Park JS, Arcaroli J, Yum HK, et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol. 2003;284:C870–C893.
Ulloa L, Messmer D. High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev. 2006;17: 189–201.
Mitola S, Belleri M, Urbinati C, et al. Cutting edge: extracellular high mobility group box-1 is a proangiogenic cytokine. J Immunol. 2006;176:12–15.
Rouhiainen A, Tumova S, Valmu L, Kalkinene N, Rauvala H. Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J Leukoc Biol. 2007;81:49–58.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zicari, A., Centonze, C., Realacci, M. et al. Estradiol 17-β and Progesterone Modulate Inducible Nitric Oxide Synthase and High Mobility Group Box 1 Expression in Human Endometrium. Reprod. Sci. 15, 559–566 (2008). https://doi.org/10.1177/1933719107312560
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719107312560